Kentucky Network for Innovation & Commercialization (“KYNETIC”)

摘要 学术研究产生的知识是健康相关创新的主要来源。转型 对商业化产品的创新发现可以改善人类健康，这是一个艰难的过程。然而， 所有利益攸关方(大学、资助机构、制药和医疗器械行业、联邦和州 政府和公众)在确定可扩展的方法以加速 将学术创新转化为生物医学产品。肯塔基州创新网络的目标 和商业化(Kynetic)是为了建立研究评估和商业化中心(REACH) 整个肯塔基州可访问的商业化资源网络加速 将学术创新转化为生物医学产品。为了实现这一目标，将实现以下目标 负责：1)建立凯恩斯的组织和协作结构；2)寻找、资助和管理产品 定义/发展项目；3)提供指导、技能发展、体验式教育和网络 与行业专家、企业家和投资者提供机会；以及4)制定和实施一项计划，以 向自给自足的实体过渡。Kynetic将在开发地区性想法的经验教训基础上再接再厉 技术转让加速器(在英国)和当前的REACH枢纽(在UL)。Kynetic将由大学领导 肯塔基州(英国)，与路易斯维尔大学(UL)和联邦商业化合作 中心(C3)，一个私营的501(C)3非营利性商业化组织。此外，Kynetic将包括所有 肯塔基州的公立地区大学和社区与技术学院系统(KCTCS)。基诺恩氏病 使命是通过提供资金、指导、教育和 相关专业知识的网络。肯塔基州已全额承诺为Kynetic提供所需的配套资金 英联邦经济发展(CED)和州立R1大学。Kynetic将由一位 领导团队由2名学术创新者、2名技术转移专业人员(来自英国和UL)和 来自合作实体(C3和CED)的2名代表。包括领导班子在内的指导委员会 来自每个参与机构、外部审查委员会和国家卫生研究院的代表将审查和 使用创新的“速杀”管理策略，评估凯诺项目，每年最多为13个项目提供资金。 我们的服务将提供给尽可能多的个人。不同的榜样，包括创新者和 来自代表性不足群体的企业家将被物色。拟议的肯塔基州覆盖范围计划将 充分利用我们丰富的资源、生态系统和丰富的经验，以最好的方式应用和扩展 创新者教育和指导的实践。Kynetic的整体影响将是前所未有的 协作和协同的机会，准备充分的创新者，全州支持创业的文化 以及提供低风险的技术，以造福健康并克服该州的健康差距。

ABSTRACT Knowledge generated by academic research is a major source of health-related innovations. Transforming innovative discoveries into commercialized products that improve human health is a difficult process. However, all stakeholders (universities, funding bodies, pharmaceutical and medical device industries, federal and state governments and the public) have a vested interest in identifying scalable approaches that accelerate the translation of academic innovations into biomedical products. The goal of the Kentucky Network for Innovation and Commercialization (KYNETIC) is to build a Research Evaluation and Commercialization Hub (REACH) network of commercialization resources accessible across the entire Commonwealth of Kentucky to accelerate translation of academic innovations into biomedical products. To reach this goal, the following aims will be conducted: 1) establish KYNETIC’s organizational and collaborative structure; 2) Find, fund and manage product definition/development projects; 3) Provide mentoring, skills development, experiential education and networking opportunities with industry experts, entrepreneurs and investors; and 4) Devise and implement a plan to transition to a self-sustaining entity. KYNETIC will build on lessons learned from developing a regional IDeA technology transfer accelerator (at UK) and a current REACH hub (at UL). KYNETIC will be led by the University of Kentucky (UK), in partnership with the University of Louisville (UL) and the Commonwealth Commercialization Center (C3), a private 501(c)3 non-profit commercialization organization. Also, KYNETIC will include all of Kentucky’s public regional universities and community and technical college system (KCTCS). KYNETIC’s mission is to nurture innovations and academic innovators by providing funding, mentoring, education and a network of relevant expertise. Required matching funds for KYNETIC have been committed in full by Kentucky Commonwealth Economic Development (CED) and the state R1 universities. KYNETIC will be directed by a leadership team consisting of 2 academic innovators, 2 technology transfer professionals (from UK and UL) and 2 representatives from partnering entities (C3 and CED). A steering committee including the leadership team and representatives from each participating institution, an External Review Board and the NIH will review and evaluate KYNETIC projects and fund up to 13 projects/yr using an innovative “quick kill” management strategy. Our services will be available to as many individuals as possible. Diverse role models including innovators and entrepreneurs from underrepresented groups will be sought. The proposed Kentucky-wide REACH program will leverage our collective wealth of resources, ecosystems and extensive experience to apply and expand best practices for innovator education and mentoring. The overall impact of KYNETIC will be unprecedented opportunities for collaboration and synergy, well-prepared innovators, a statewide pro-entrepreneurial culture and delivery of de-risked technologies to benefit health and overcome the state’s health disparities.